Mizuho Maintains Neutral on Nutrien, Raises Price Target to $75
Mizuho analyst Christopher Parkinson maintains Nutrien (NYSE:NTR) with a Neutral and raises the price target from $70 to $75.
Nutrien Q3 EPS $1.38 Beats $1.22 Estimate
Nutrien (NYSE:NTR) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $1.22 by 13.11 percent. This is a 500 percent increase over earnings of $0.23 per share from the same period
Earnings Scheduled For November 1, 2021
Companies Reporting Before The Bell
• ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter.
A Look Into Nutrien’s Debt
Shares of Nutrien (NYSE:NTR) moved higher by 18.41% in the past three months. Before having a look at the importance of debt, let us look at how much debt Nutrien has.
Mizuho Initiates Coverage On Nutrien with Neutral Rating, Announces Price Target of $70
Mizuho analyst Christopher Parkinson initiates coverage on Nutrien (NYSE:NTR) with a Neutral rating and announces Price Target of $70.
RBC Capital Maintains Outperform on Nutrien, Raises Price Target to $80
RBC Capital analyst Andrew Wong maintains Nutrien (NYSE:NTR) with a Outperform and raises the price target from $73 to $80.
Unusual Options Activity Insight: Nutrien
On Tuesday, shares of Nutrien (NYSE:NTR) saw unusual options activity. After the option alert, the stock price moved up to $63.14.
Nutrien Q2 Adj. EBITDA $2.215B vs $1.721B In Same Qtr. Last Year, Sales $8.76B Up From $8.42B YoY
Nutrien (NYSE:NTR) reported $8.76 billion in sales this quarter. This is a 4.12 percent increase over sales of $8.42 billion the same period last year.
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.